Table 7.
Summary of four-way ANOVA comparing associations between HC-SSs and NC-GEsa
Source | F (df) | p | Post hoc analysis (if any) and corresponding p value (Tukey's range test) | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Main effect | GE | 90.4 (3,27) | 3.37 × 10−14 | TB versus SS | TB versus DS | TB versus US | SS versus DS | SS versus US | DS versus US | |||||
NS | 3.843 × 10−9 | 3.787 × 10−9 | 3.840 × 10−9 | 3.786 × 10−9 | NS | |||||||||
Stage | 242.5 (1,27) | 5.19 × 10−15 | NA | |||||||||||
AP | 54.6 (1,27) | 6.04 × 10−8 | NA | |||||||||||
ROI | 24.9 (9,27) | 7.77 × 10−11 | LT | CG | OF | PF | PC | MTO | MOP | IS | LP | LO | ||
LO versus | 0.0052 | 1.295 × 10−7 | 1.567 × 10−7 | 1.583 × 10−7 | 0.0208 | NS | 0.0002 | NS | 1.815 × 10−5 | NA | ||||
MOP versus | NS | 0.0017 | 0.0279 | 0.0294 | NS | 0.0267 | NA | 0.0480 | NS | 0.0002 | ||||
LP versus | NS | 0.0217 | NS | NS | NS | 0.0021 | NS | 0.0041 | NA | 1.815 × 10−5 | ||||
CG versus | 8.018 × 10−5 | NA | NS | NS | 1.895 × 10−5 | 2.822 × 10−7 | 0.0017 | 4.092 × 10−7 | 0.0217 | 1.295 × 10−7 | ||||
Two-way interaction | GE × stage | 0.2 (3,27) | 0.9128 | NA | ||||||||||
GE × AP | 10.9 (3,27) | 0.0001 | aPH versus pHC | TB | DS | SS | US | |||||||
1.0000 | 0.0085 | 4.203 × 10−7 | 0.1645 | |||||||||||
GE × ROI | 2.0 (27,27) | 0.0354 | LT | CG | OF | PF | PC | MTO | MOP | IS | LP | LO | ||
TB versus SS | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | ||||
TB versus DS | NS | 0.0144 | NS | NS | NS | NS | NS | 0.0029 | 0.0333 | NS | ||||
TB versus US | NS | 0.0071 | NS | NS | NS | NS | 0.0054 | NS | 0.0050 | 0.0089 | ||||
SS versus DS | 0.0040 | NS | NS | NS | NS | NS | NS | 0.0005 | NS | NS | ||||
SS versus US | 0.0060 | NS | 0.0392 | NS | NS | 0.0197 | NS | NS | NS | 0.0293 | ||||
DS versus US | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS | ||||
Stage × AP | 1.1 (1,27) | 0.3008 | NA | |||||||||||
Stage × ROI | 7.1 (9,27) | 3.28 × 10−5 | N2 versus N3 | LT | CG | OF | PF | PC | MTO | MOP | IS | LP | LO | |
2.696 × 10−5 | NS | 9.627 × 10−7 | 0.0047 | 0.0003 | NS | 0.0824 | 1.304 × 10−5 | 0.0032 | NS | |||||
AP × ROI | 1.8 (9,27) | 0.1213 | NA | |||||||||||
Three-way interaction | GE × stage × AP | 11.1 (3,27) | 0.0001 | N2 aHC | N2 pHC | N3 aHC | N3 pHC | |||||||
NC-SS, N2 pHC | 7.634 × 10−6 | NA | 5.141 × 10−7 | 1.653 × 10−5 | ||||||||||
NC-DS, N3 aHC | 1.038 × 10−5 | 7.725 × 10−7 | NA | 0.0196 | ||||||||||
NC-US, N3 aHC | 9.516 × 10−7 | 1.190 × 10−5 | NA | 0.0016 | ||||||||||
GE × stage × ROI | 1.0 (27,27) | 0.4610 | NA | |||||||||||
GE × AP × ROI | 1.7 (27,27) | 0.0907 | NA | |||||||||||
Stage × AP × ROI | 3.0 (9,27) | 0.0139 | Mostly NS (e.g., for orbitofrontal, p = 1.138 × 10−5 for N2 pHC vs N3 aHC, and p = 4.444 × 10−6 for N3 pHC vs N3 aHC) |
aFor each HC-NC electrode pair and sleep stage (N2 vs N3), the significance of the NC-GE occurrence times relative to the HC-SS onset was determined (see Fig. 3B; Materials and Methods). We then tallied the proportion of significant channel pairs according to their HC location (aHC, pHC), NC location (see Extended Data Table 4-1; Fig. 5A), and GE type (TB, DS, SS, US). These proportions were then entered into ANOVA. LO, Lateral occipital; LT, lateral temporal; CG, cingulate; OF, orbitofrontal; PF, prefrontal; PC, paracentral; MTO, medial temporo-occipital; MOP, medial occipito-parietal; IS, insula; LP, lateral parietal; NS, not significant (for post hoc Tukey's range tests, p > 0.1).